← FDA Drug Approvals (Drugs@FDA)

NEURONTIN

NDA · New Drug Application · Sponsor: VIATRIS · Approved 2000-03-02

Drug application

FDA Application #

NDA021129

Application type

New Drug Application

Brand name

NEURONTIN

Generic name

GABAPENTIN

Active ingredients

GABAPENTIN

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

VIATRIS

Manufacturer

Parke-Davis Div of Pfizer Inc

First approval

2000-03-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown